Medicare Enrolled

Dr. Mark Goldstein, MD

Rheumatology · Staten Island, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1478 VICTORY BLVD, Staten Island, NY 10301
7184470055
In practice since 2005 (20 years)
NPI: 1679568885 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Goldstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goldstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Goldstein

Dr. Mark Goldstein is a rheumatology specialist in Staten Island, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Goldstein performed 76,983 Medicare services across 952 unique beneficiaries.

Between the years covered by Open Payments, Dr. Goldstein received a total of $35,790 from 44 pharmaceutical and/or device companies across 1298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Goldstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 6% volume in NY $35,790 industry payments

Medicare Practice Summary

Medicare Utilization ↗
76,983
Medicare services
Top 6% in NY for rheumatology
952
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,849 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
51,640 $4 $11
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
7,826 $34 $70
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
7,250 $11 $50
Denosumab injection (Prolia/Xgeva) 5,700 $18 $32
Hymovis intra-articular injection
An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space.
2,233 $13 $36
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
693 $72 $125
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
353 $68 $250
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
273 $126 $584
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
272 $1 $30
Injection, methylprednisolone acetate, 40 mg 140 $6 $38
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
135 $74 $194
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
122 $27 $150
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
111 $47 $85
Methylprednisolone acetate injection, 20 mg
A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered.
99 $4 $38
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
55 $99 $175
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
43 $136 $360
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
38 $35 $120
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.3% high complexity
78.5% medium
1.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$35,790
Total received (2018-2024)
Avg $5,113/year across 7 years
Top 14% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,298
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,053 (64.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,646 (24.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,091 (11.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,001
2023
$3,933
2022
$3,930
2021
$2,580
2020
$1,610
2019
$3,838
2018
$15,897

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,267
Amgen Inc.
$432
UCB, Inc.
$322
Janssen Biotech, Inc.
$267
PFIZER INC.
$245
AstraZeneca Pharmaceuticals LP
$227
Radius Health, Inc.
$204
Novartis Pharmaceuticals Corporation
$182
Lilly USA, LLC
$181
Boehringer Ingelheim Pharmaceuticals, Inc.
$154
GENZYME CORPORATION
$105
Aurinia Pharma U.S., Inc.
$95
Genentech USA, Inc.
$73
E.R. Squibb & Sons, L.L.C.
$70
GlaxoSmithKline, LLC.
$53
Fresenius Kabi USA, LLC
$37
Fidia Pharma USA Inc.
$29
ANI Pharmaceuticals, Inc.
$21
Mallinckrodt Hospital Products Inc.
$21
SCILEX PHARMACEUTICALS INC.
$17
Top 3 companies account for 50.5% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Pharma plc
$8,646
PFIZER INC.
$6,047
ABBVIE INC.
$3,625
Amgen Inc.
$3,158
Janssen Biotech, Inc.
$1,943
Novartis Pharmaceuticals Corporation
$1,180
AbbVie Inc.
$1,123
AstraZeneca Pharmaceuticals LP
$989
E.R. Squibb & Sons, L.L.C.
$837
AbbVie, Inc.
$830
UCB, Inc.
$810
Lilly USA, LLC
$806
GlaxoSmithKline, LLC.
$738
Aurinia Pharma U.S., Inc.
$574
Genentech USA, Inc.
$570
Horizon Therapeutics plc
$548
Celgene Corporation
$422
Regeneron Healthcare Solutions, Inc.
$350
Radius Health, Inc.
$326
Antares Pharma, Inc.
$260
Boehringer Ingelheim Pharmaceuticals, Inc.
$246
Mallinckrodt Enterprises LLC
$212
Mallinckrodt Hospital Products Inc.
$194
GENZYME CORPORATION
$192
FIDIA PHARMA USA INC.
$183
Flexion Therapeutics, Inc.
$178
Hikma Pharmaceuticals USA
$177
Fidia Pharma USA Inc.
$119
Fresenius Kabi USA, LLC
$90
Daiichi Sankyo Inc.
$77
Takeda Pharmaceuticals U.S.A., Inc.
$45
Sebela Pharmaceuticals Inc.
$42
West-Ward Pharmaceuticals
$37
Mallinckrodt LLC
$31
Sobi, Inc
$31
Bioventus LLC
$22
ANI Pharmaceuticals, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$17
MEDAC PHARMA, INC.
$17
Kaleo, Inc.
$16
Ferring Pharmaceuticals Inc.
$16
Endo Pharmaceuticals Inc.
$15
MEDEXUS PHARMA, INC.
$13
SANOFI-AVENTIS U.S. LLC
$12
Top 3 companies account for 51.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · BOSULIF · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Durolane · EUFLEXXA · EVENITY · Enbrel · Evzio · FORTEO · GLOPERBA · HUMIRA · HYALGAN · HYMOVIS · Humira · Hymovis · IDACIO · ILARIS · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Kineret · Kloxxado · LUPKYNIS · LYRICA · Mitigare · Morphabond ER · Movantik · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORENCIA · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPEVIGO · STELARA · SYNVISC-ONE · TALTZ · TAVNEOS · TREMFYA · Tavneos · Trintellix · Tymlos · Uloric · XELJANZ · XENPOZYME · XIAFLEX · XYOSTED · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (64%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Staten Island?
Compare rheumatologists in the Staten Island area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
383
Per 100K population
77.7
County median income
$98,290
Nearest hospital
RICHMOND UNIVERSITY MEDICAL CENTER
1.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Goldstein is a mixed practice specialist, with above-average Medicare volume (top 6% in NY), with low-engagement industry engagement in the top 14% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Goldstein experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Goldstein performed 51,640 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goldstein receive payments from pharmaceutical companies?
Yes. Dr. Goldstein received a total of $35,790 from 44 companies across 1,298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goldstein's costs compare to other rheumatologists in Staten Island?
Dr. Goldstein's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goldstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →